Phosphodiesterase 4 — Drug Target

All drugs that target Phosphodiesterase 4 — marketed and clinical-stage. Includes 4 drug classes acting on this target.

Drug classes

Phosphodiesterase 4 Inhibitor [EPC] · Phosphodiesterase 4 inhibitor · Phosphodiesterase-4 inhibitor · phosphodiesterase 4 inhibitor

Marketed (1)

• Eucrisa · Anacor Pharms Inc · Phosphodiesterase 4 Inhibitor [EPC] · Immunology
  Eucrisa works by blocking the phosphodiesterase 4 enzyme, which helps reduce inflammation in the skin.

Phase 3 pipeline (3)

• Roflumilast Cream 0.15% · Arcutis Biotherapeutics, Inc. · Phosphodiesterase 4 inhibitor · Immunology
  Roflumilast is a phosphodiesterase 4 inhibitor that reduces inflammation by blocking the action of phosphodiesterase 4.
• Roflumilast Cream 0.3% · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Phosphodiesterase-4 inhibitor · Respiratory
  Roflumilast is a phosphodiesterase-4 inhibitor, which reduces inflammation by inhibiting the production of pro-inflammatory cytokines.
• Topical roflumilast · Arcutis Biotherapeutics, Inc. · phosphodiesterase 4 inhibitor · Dermatology
  Topical roflumilast is a phosphodiesterase 4 inhibitor that reduces inflammation in the skin.